Search research articles
Contact Us
Filters
Showing results (101-110 of 104) with videos related to
Page
of 11
Sort By:
You have reached the last page of results.
This site can display upto 104 results.
Ebiomedicine
|
June 29, 2024
GABA-mediated inhibition of human CD4<sup>+</sup> T cell functions is enhanced by insulin but impaired by high glucose levels
Zhe Jin, Hayma Hammoud, Amol Keshavasa Bhandage, et al.
American Journal of Human Genetics
|
March 12, 2021
Monoallelic and bi-allelic variants in NCDN cause neurodevelopmental delay, intellectual disability, and epilepsy
Ambrin Fatima, Jan Hoeber, Jens Schuster, et al.
American Journal of Human Genetics
|
March 4, 2022
Monoallelic and bi-allelic variants in NCDN cause neurodevelopmental delay, intellectual disability, and epilepsy
Ambrin Fatima, Jan Hoeber, Jens Schuster, et al.
Journal of Medicinal Chemistry
|
January 12, 2023
Discovery and Hit-to-Lead Optimization of Benzothiazole Scaffold-Based DNA Gyrase Inhibitors with Potent Activity against <i>Acinetobacter baumannii</i> and <i>Pseudomonas aeruginosa</i>
Andrej Emanuel Cotman, Martina Durcik, Davide Benedetto Tiz, et al.
Page
of 11
Search research articles
Search
Showing results (101-110 of 104) with videos related to
Sort By:
Page
of 11
You have reached the last page of results.
This site can display upto 104 results.
Ebiomedicine
|
June 29, 2024
GABA-mediated inhibition of human CD4<sup>+</sup> T cell functions is enhanced by insulin but impaired by high glucose levels
Zhe Jin, Hayma Hammoud, Amol Keshavasa Bhandage, et al.
American Journal of Human Genetics
|
March 12, 2021
Monoallelic and bi-allelic variants in NCDN cause neurodevelopmental delay, intellectual disability, and epilepsy
Ambrin Fatima, Jan Hoeber, Jens Schuster, et al.
American Journal of Human Genetics
|
March 4, 2022
Monoallelic and bi-allelic variants in NCDN cause neurodevelopmental delay, intellectual disability, and epilepsy
Ambrin Fatima, Jan Hoeber, Jens Schuster, et al.
Journal of Medicinal Chemistry
|
January 12, 2023
Discovery and Hit-to-Lead Optimization of Benzothiazole Scaffold-Based DNA Gyrase Inhibitors with Potent Activity against <i>Acinetobacter baumannii</i> and <i>Pseudomonas aeruginosa</i>
Andrej Emanuel Cotman, Martina Durcik, Davide Benedetto Tiz, et al.
Page
of 11